Electroencephalography (EEG), first recorded in 1924, has undergone a century of advancements and now plays a cornerstone role in diagnosing and researching brain disorders. It has significantly enhanced our understanding of brain function, facilitated the diagnosis of neurological conditions, and driven major advances in neuroscience.
Traditionally viewed as non-invasive and ethically straightforward, EEG has received limited attention in neuroethics discussions. However, the rapid integration of artificial intelligence (AI) into EEG technology introduces new ethical complexities that demand urgent consideration, particularly in neurological innovation and patient care.
We systematically reviewed 108 peer-reviewed articles published between 2010 and 2025 to explore these emerging challenges. Our findings highlight three major ethical concerns: algorithmic bias, the evolving challenges of informed consent, and the protection of mental privacy and neural data. While AI enhances EEG by improving the detection of abnormal brain activity and accelerating diagnostic workflows, it also introduces significant risks.
Algorithmic bias may lead to misdiagnosis or unequal treatment outcomes, particularly among underrepresented patient groups. This underscores the need for rigorous validation practices and diverse training datasets.
When AI-driven EEG assessments are used, informed consent becomes increasingly complex. Patients must understand the EEG procedure and how AI interprets their brain data, which poses particular challenges for individuals with cognitive impairments. Clear, compassionate communication strategies are essential to uphold patient autonomy and care trust.
Moreover, the rise of portable EEG devices outside clinical settings raises significant concerns regarding mental privacy. The possibility of "mind reading" through accessible brain data and inadequate regulatory oversight heightens the risk of misuse.
Alarmingly, many developers of portable EEG technologies remain unaware of existing ethical, legal, and social issues (ELSI) guidelines, highlighting a critical gap in ethical adherence.
To address these challenges, we propose a three-tier ethical framework for AI-driven EEG systems, focusing on: (1) algorithmic accountability to ensure fairness and transparency, (2) strengthened informed consent processes to protect patient autonomy, and (3) robust measures for mental privacy and data security to safeguard against misuse and exploitation.
The proliferation of AI in EEG highlights the urgent need for interdisciplinary collaboration among ethicists, neuroscientists, clinicians, and AI developers. Establishing shared ethical standards is essential to ensure that innovations in brain disorder diagnosis and treatment remain responsible, inclusive, and equitable. As EEG technology continues to evolve, further research is essential to evaluate the real-world impact of our proposed framework in clinical settings. Only through proactive efforts can we ensure that the next century of EEG advances will transform brain disorder diagnosis and neurology and remain both scientifically and ethically sound.